The expression of PIGR, DEFB1, LTF, CLU, SCGB2A1 and S100A7, while having a positive role in cancer elimination, were either downregulated or not changed in all or some of the BC subtypes (Table 1). This evidence concerns the gene SCGB2A1 and breast cancer.